OUTCOME OF THE BOARD MEETING HELD ON 3RD FEBRUARY, 2026

Emphasis Of MatterRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹244.05

prior close

₹251.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-0.1% vs market

Other Textile Products peers, median of 178sector+0.9%+0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.0

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2+1.3-0.1+0.9+0.3

Next day

+2.1+0.3+1.8+0.5+1.7

+0.7-0.5+1.1+0.6+0.1

-1.7+2.1-3.8+1.7-3.4

-2.9+3.1-6.0+1.4-4.3

-4.1+2.6-6.6+1.2-5.3

-3.7+0.6-4.3+0.1-3.9

15d

-2.9-1.4-1.4-2.6-0.2

-5.8-6.9+1.2-6.7+1.0

+1.4-7.7+9.1-10.2+11.6

+37.7+7.0+30.7+0.4+37.2

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 178Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shri Dinesh Mills' board, meeting on February 3, 2026, approved unaudited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, with a clean limited review report from auditor R.K. Doshi & Co. LLP. The board reappointed Ms. Reshma Patel as Non-Executive Independent Director for another five-year term starting March 15, 2026, subject to shareholder approval. Remuneration terms for Chairman & MD Shri Bharatbhai Patel were renewed for the period April 1, 2026 to March 31, 2028. The company also approved an investment of about Rs. 70.72 lakh in 7,07,200 0.01% Optionally Convertible Non-Cumulative Preference Shares of its wholly owned subsidiary Fernway Technologies Ltd. The auditor's report highlighted the completed disposal of subsidiary Dinesh Remedies Limited (effective September 3, 2025) as an emphasis-of-matter item, with the conclusion unaltered.

Likely market impact

Routine quarterly results announcement with no negative audit qualifications; the subsidiary disposal is already completed, and the preference share investment in Fernway is a small inter-group move. Shareholders should watch for shareholder approval on Ms. Reshma Patel's reappointment and the MD remuneration resolution at the next general meeting.